Clinicians have some influence over social determinants that affect the health of patients, but it’s important for partnerships to be developed to further improve the negative impacts of certain determinants, said Charlie Fazio, MD, senior vice president and medical director of HealthPartners.
Clinicians have some influence over social determinants that affect the health of patients, but it’s important for partnerships to be developed to further improve the negative impacts of certain determinants, said Charlie Fazio, MD, senior vice president and medical director of HealthPartners.
Transcript (slightly modified)
How much of primary care innovation should factor in and address social determinants of health?
We think about social determinants, and I love the model that says, “if we think about health and well-being, what we do in healthcare only contributes about 20% to that.”
So, as a clinician, I can help influence some of the components of the social determinants. I can help you think through your personal habits—whether or not you use tobacco, how you eat, whether or not you move on a regular basis. I can help you think through your sense of well-being and your satisfaction with life, and help bring behavioral health supports to play when you need those.
But, I have a lot less influence on whether you have access to healthy foods, and whether you have shelter that feels safe, and where you live—all of which contribute to health and well-being. So, as a clinician, I can help influence some of it, I can help with the healthcare part of it, and then for the rest of it we need to find partnerships.
I think clinics and hospitals work in communities, businesses work in communities, and it’s important for all of those to think about the health of those communities, and how we can work to influence the social determinants so that everybody has a chance to be as healthy and have a greater sense of well-being.
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More
It Take a Village in Cancer Care: A Q&A With David Nguyen, MD
July 23rd 2025David Nguyen, MD, medical oncologist with Tufts Medicine and Lowell General Hospital, discusses the evolving landscape of advanced cancer treatments like chimeric antigen receptor T-cell therapy and bispecific antibodies
Read More
Best of Managed Care Cast: Top 5 Episodes From the First Half of 2025
July 18th 2025These interviews are the top episodes, by listens, from among the 21 podcast episodes The American Journal of Managed Care® produced over the first half of 2025. Give them all another listen, and perhaps learn something new.
Read More
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More
It Take a Village in Cancer Care: A Q&A With David Nguyen, MD
July 23rd 2025David Nguyen, MD, medical oncologist with Tufts Medicine and Lowell General Hospital, discusses the evolving landscape of advanced cancer treatments like chimeric antigen receptor T-cell therapy and bispecific antibodies
Read More
Best of Managed Care Cast: Top 5 Episodes From the First Half of 2025
July 18th 2025These interviews are the top episodes, by listens, from among the 21 podcast episodes The American Journal of Managed Care® produced over the first half of 2025. Give them all another listen, and perhaps learn something new.
Read More
2 Commerce Drive
Cranbury, NJ 08512